130 related articles for article (PubMed ID: 7056602)
1. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight immunomodifiers produced by microorganisms.
Umezawa H; Ishizuka M
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
[TBL] [Abstract][Full Text] [Related]
3. Screening of small molecular microbial products modulating immune responses and bestatin.
Umezawa H
Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
[TBL] [Abstract][Full Text] [Related]
4. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
5. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
6. Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effort.
Umezawa H
Rev Infect Dis; 1984; 6(3):412-20. PubMed ID: 6234644
[TBL] [Abstract][Full Text] [Related]
7. Fundamental studies on bestatin: a small molecular microbial product enhancing immune response.
Umezawa H
Recent Results Cancer Res; 1981; 76():209-21. PubMed ID: 7232851
[No Abstract] [Full Text] [Related]
8. [Experimental and clinical studies of bestatin as an immunomodulator].
Miwa H; Oka T; Tsurumi T; Sakae Y; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1019-24. PubMed ID: 7184437
[TBL] [Abstract][Full Text] [Related]
9. Small molecular microbial products enhancing immune response.
Umezawa H
Antibiot Chemother (1971); 1978; 24():9-18. PubMed ID: 655681
[TBL] [Abstract][Full Text] [Related]
10. Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin.
Umezawa H
Cancer Treat Rep; 1984 Jan; 68(1):137-44. PubMed ID: 6692425
[TBL] [Abstract][Full Text] [Related]
11. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
12. The relationships between enzyme inhibitors and function of mammalian cells.
Aoyagi T; Umezawa H
Acta Biol Med Ger; 1981; 40(10-11):1523-9. PubMed ID: 7044007
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight immunomodifiers produced by micro-organisms.
Umezawa H
Biotechnol Genet Eng Rev; 1985; 3():255-73. PubMed ID: 2936359
[No Abstract] [Full Text] [Related]
14. Immunopotentiation in infectious disease, I. Effect of bestatin on the immune response.
Ormrod DJ; Cawley S; Miller TE
Chemioterapia; 1985 Aug; 4(4):313-23. PubMed ID: 3876888
[TBL] [Abstract][Full Text] [Related]
15. Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function.
Mathé G
Biomed Pharmacother; 1991; 45(2-3):49-54. PubMed ID: 1912369
[TBL] [Abstract][Full Text] [Related]
16. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
[TBL] [Abstract][Full Text] [Related]
17. Bestatin as an experimental tool in mammals.
Scornik OA; Botbol V
Curr Drug Metab; 2001 Mar; 2(1):67-85. PubMed ID: 11465152
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.
Saiki I; Murata J; Watanabe K; Fujii H; Abe F; Azuma I
Jpn J Cancer Res; 1989 Sep; 80(9):873-8. PubMed ID: 2513304
[TBL] [Abstract][Full Text] [Related]
19. [The effect of mefenamic acid on the immunity indices and hemostatic system in cancer patients and on the cathepsin D-like protease activity in the tissues in cancer of the large intestine].
Kliachkin BM; Basargin ST; Timofeev IV; Khaliulin IuG; Dorofeev SA; Alekseenko LD; Gumeniuk ML
Vopr Onkol; 1992; 38(7):792-7. PubMed ID: 1338673
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
Ueda M; Ueki M; Fujii H; Yoshizawa K; Nakajima M
J Med; 1997; 28(3-4):175-90. PubMed ID: 9355022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]